| 60 | CD8+ T cells in the
murine renal cancer Renca: cytotoxic activity and anti-tumor
effects in vivo Seki N1, Brooks AD2, Mason AT1, Wine JW1, Back TC2, Parsoneault EM2, Wiltrout RH1, and Sayers TJ2 1Laboratory of Experimental Immunology, CCR, NCI-Frederick, 2SAIC-Frederick, Frederick, MD |
| 61 | Assessment of Stability
of Expression of Tumor-Associated Antigens in an Allogeneic
Ovarian Cancer Cell Vaccine Selvan RS1, Malone CC1, Bauer JA1, Brown BW1, Ravi S1, Spencer KS1, Chen Y2, Dan Q2, Jadus MR2, Lebeck LK3, Heinemann FS1, Dillman RO1 1Hoag Cancer Center, Newport Beach; 2VA Administration, Long Beach; 3University of California, San Diego, CA |
| 62 | IFN-γ responsiveness
of mouse renal cell carcinoma cells contributes to host-mediated
antimetastatic effects Lynnette H. Shorts1, M. Eilene Gruys1, Timothy C. Back2, Jon M. Wigginton3, Jeff Subleski1, Robert H. Wiltrout1 1NCI-CCR and 2SAIC Frederick, Frederick, MD 3POB, Bethesda, MD |
| 63 | FLT3 Ligand: A Potential
New Immunorestorative Agent? Sinha, Manoj; Fry, Terry; Mackall, Crystal L. Pediatric Oncology, NCI, NIH, Bethesda, MD |
| 64 | Induction of MIG
and IP-10 gene expression by LPS and IL-12/pulse IL-2 in kidney
messangial cells can use IFN-γ dependent and independent pathways Jeff Subleski1, Jong-Wook Park2, Chris Wallace1, Jon Wigginton3 and Robert H. Wiltrout1 1Experimental Therapeutics Section, Laboratory of Experimental Immunology, Division of Basic Sciences, NCI-FCRDC, Frederick, MD; 2Institute for Medical Sciences of Keimyung University, Taegu Korea; 3Division of Basic Sciences and Pediatric Oncology Branch, Division of Clinical Sciences, NIH, Bethesda, MD |
| 65 | Immunologic and Hematopoietic
Effects of Recombinant Human Prolactin After Syngeneic Bone
Marrow Transplantation in Mice Sun, Rui; Welniak, Lisbeth; Tian, Zhigang; Murphy, William J. LMI, NCI at Frederick Frederick, MD |
| 66 | Tumors induce apoptosis
in T cells by both caspase-8 dependent receptor mediated apoptosis
and caspase-8 independent pathways Charlie Tannenbaum, Patricia Rayman, Luis Molto, Ronald Bukowski and James Finke Cleveland Clinic Foundation |
| 67 | Dendritic Cell Expression of a
Modified Vaccinia Ankara Virus Encoding MUC1 and IL-2 Trevor KT1, Hersh EM1, Brailey J1, Balloul J-M2, Acres B2 1Arizona Cancer Center, Tucson, AZ; 2Transgene SA, Strasbourg, France |
| 68 | Membrane Expression of Macrophage
Colony Stimulating Factor (mM-CSF) on MADB106 Breast Cancer
Cells is Not Associated with In Vitro Cytotoxicity by Macrophages
But is Associated with the Induction Lasting Tumor Immunity
Against Syngeneic Breast Cancer Cells In Vivo Trinh H, Tran TV, Williams CC, Dan Q, Sanchez R, Delgado C, Chen Y, Sippel B, Jeffes EWB, Wepsic HT, Jadus MR Departments of Laboratory Service and Dermatology Service, Veterans Affairs Medical Center, Long Beach CA and The University of California, Irvine, CA |
| 69 | Preferential apoptosis
of the CD8+CD28- T cell subset of effector cells in the peripheral
blood of patients with head and neck cancer Takashi Tsukishiro, Albert Donneberg and Theresa L. Whiteside University of Pittsburgh Cancer Institute, Pittsburgh, PA |
| 70 | Real-time polymerase
chain reaction monitoring of Ep-CAM-induced T cell stimulation
in lung cancer patients and healthy individuals using the LightCycler™
technology Urosevic M2, Nestle FO2, Dummer R2, Stahel RA1, Trojan A1 1Division of Oncology, Department of Internal Medicine; 2Department of Dermatology, University Hospital Zurich, Zurich, Switzerland |
| 71 |
Can imiquimod awake basal cell carcinomas from immunological
dormancy? – gene expression profiling of basal cell carcinomas
treated with imiquimod |
